Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramCHIEF OPERATING OFFICERCIK 0001967163
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Patel AnishCHIEF OPERATING OFFICER |  ELVNEnliven Therapeutics, Inc.Grant or award | A | — 120.0K sh | Feb 17, 2026 traded Feb 12, 2026 | |
Patel AnishCHIEF OPERATING OFFICER |
| ELVNEnliven Therapeutics, Inc. Grant or award |
| A |
| — 20.0K sh |
| Feb 17, 2026 traded Feb 12, 2026 |
| 19 | Patel AnishCHIEF OPERATING OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.34M 48.1K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 6 | Patel AnishCHIEF OPERATING OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,926 243 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Patel AnishCHIEF OPERATING OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $103K 4,958 sh | Dec 10, 2025 traded Dec 8, 2025 |
| 6 | Patel AnishCHIEF OPERATING OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 1,705 sh | Dec 10, 2025 traded Dec 8, 2025 |
| 21 | Patel AnishCHIEF OPERATING OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 613 sh | Nov 12, 2025 traded Nov 7, 2025 |
| 24 | Patel AnishCHIEF OPERATING OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 6,054 sh | Nov 12, 2025 traded Nov 7, 2025 |